Frontage HoldingsFGHQF -3.57%58 PEG Ratio is 2.52 as of Jul. 06, 2026, which is 227% above its 10-year median of 0.77. GuruFocus rates FGHQF with a GF Score™ of 58/100 and a GF Value™ of $0.23 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 94 Biotechnology companies, Frontage Holdings ranks worse than 60.64% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Frontage Holdings's PEG Ratio or its related term are showing as below:
FGHQF'
s PEG Ratio Range Over the Past 10 Years
Min: 0.24 Med: 0.77 Max: 2.79
Current: 2.4
During the past 10 years, Frontage Holdings's highest PEG Ratio was 2.79. The lowest was 0.24. And the median was 0.77.
FGHQF's PEG Ratio is ranked worse than 60.64% of 94
companies
in the Biotechnology industry
Industry Median: 2.03
vs FGHQF: 2.40
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Frontage Holdings (OTCPK:FGHQF) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Frontage Holdings PEG Ratio Related Terms
Frontage Holdings PEG Ratio Historical Data
* Premium members only.
The historical data trend for Frontage Holdings's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Frontage Holdings's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Frontage Holdings PEG Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Frontage Holdings's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Frontage Holdings's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Frontage Holdings (FGHQF) has a PEG Ratio of 2.52 as of Jul. 06, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Frontage Holdings and its competitors. This is 227% above median its historical median of 0.77. Over the past decade, Frontage Holdings' PEG Ratio has ranged from 0.24 to 2.79. According to the industry distribution chart, Frontage Holdings ranks #57 out of 94 companies in the Biotechnology industry, placing it in the top 60.6%.
Is Frontage Holdings' PEG Ratio too high?
Frontage Holdings' current PEG Ratio of 2.52 is 227% above median its 10-year median of 0.77. Over the past 10 years, this metric has ranged from a low of 0.24 to a high of 2.79. The Biotechnology industry median PEG Ratio is 2.03. Frontage Holdings' value of 2.52 is 24.1% above this industry median. Based on the distribution chart, Frontage Holdings ranks #57 out of 94 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Frontage Holdings has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Frontage Holdings' PEG Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Frontage Holdings ranks #57 out of 94 companies for PEG Ratio. This places Frontage Holdings in the lower half of its industry. The industry median PEG Ratio is 2.03. Frontage Holdings' value of 2.52 is 24.1% above this benchmark. Historically, Frontage Holdings' own PEG Ratio has ranged from 0.24 to 2.79 over the past decade. While the company's 10-year median is 0.77 vs. the industry median of 2.03, Frontage Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Biotechnology company?
The median PEG Ratio among Biotechnology companies is 2.03, based on 94 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Frontage Holdings's current PEG Ratio of 2.52 is 24.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Frontage Holdings and its competitors. For the Biotechnology industry, the median PEG Ratio is 2.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Frontage Holdings's current PEG Ratio is 2.52, which is 227% above median its own 10-year median of 0.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Frontage Holdings stock overvalued right now?
Based on GuruFocus' analysis, Frontage Holdings (FGHQF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.23, compared to a current price of $0.14 — trading 41.3% below its estimated fair value. The current PEG Ratio is 2.52, which is 227% above median its 10-year median of 0.77 and 24.1% above the Biotechnology industry median of 2.03. Frontage Holdings' overall GF Score™ is 58/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Frontage Holdings (FGHQF), the current PEG Ratio is 2.52 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Frontage Holdings (FGHQF) Overvalued in 2026?
Based on GuruFocus' analysis, Frontage Holdings stock appears to be undervalued.
The current stock price of $0.14 is trading 41.3% below its estimated GF Value™ of $0.23.
GuruFocus considers Frontage Holdings to be Possible Value Trap.
Key valuation signals for FGHQF:
PEG Ratio: 2.52 (227% above median its 10-year median of 0.77)
GF Value™: $0.23 vs. price of $0.14 (41.3% below fair value)
Industry Position: 24.1% above the Biotechnology median (#57 of 94)
No single metric tells the full story. See the FGHQF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Frontage Holdings Corp provides laboratory and related services to pharmaceutical and agrochemical companies. Its segments include North America and Europe segment, including drug discovery, drug development, pharmaceutical product development and laboratory testing in the USA, Canada and Europe; and PRC segment, including drug discovery, drug development, pharmaceutical product development and laboratory testing in the PRC. It derives majority of the revenue from North America and Europe segment. Geographically majority of the revenue is derived from USA and Canada.
58GF Score
Get the complete analysis for FGHQF
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FGHQF has been successfully added to your 
